Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Adaptive Biotechnologies
ISIN US00650F1093
|WKN A2PLR5
Market cap (in EUR)
3 475 M
Country
États-Unis
Sector
Santé
Dividend yield
0,00%
Overview
Description
Adaptive Biotechnologies Corp. se consacre au développement d'une plateforme de médecine immunitaire. Ses produits et services comprennent l'immunoSEQ, le clonoSEQ, la thérapie cellulaire et les vaccins. La société a été fondée par Chad Robins, Harlan Robins et Chris Carlson le 8 septembre 2009 et son siège social se trouve à Seattle, WA.
Santé Services de santé Services de santé divers États-Unis
Financials
Key metrics
| Market capitalisation, EUR | 3 475 M |
| EPS, EUR | -0,35 |
| P/B ratio | 28,3 |
| P/E ratio | - |
| Dividend yield | 0,00% |
Income statement (2025)
| Revenue, EUR | 246 M |
| Net income, EUR | -53 M |
| Profit margin | -21,48% |
What ETF is Adaptive Biotechnologies in?
There are 43 ETFs which contain Adaptive Biotechnologies. All of these ETFs are listed in the table below. The ETF with the largest weighting of Adaptive Biotechnologies is the ARK Genomic Revolution UCITS ETF USD Accumulating.
Savings plan offers
Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
Detailed comparison of all offers
Source: justETF Research; as of 8/2026. The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded. In addition to the fees charged by online brokers, additional costs may apply. The stated fees are thus exclusive of standard market spreads, commissions, product costs and third-party fees. Please note: No guarantee can be given for the completeness, correctness and accuracy of the content listed. The information on the online brokers' homepages is decisive. Investments in securities involve risks.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable AG. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable AG. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.